Effect of Upadacitinib on Biomarkers of Systemic Inflammation in Patients with Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2026 Mar. 10 [cited 2026 May 1];10(2):s742. Available from: https://skin.dermsquared.com/skin/article/view/4096